Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow-226031, India.
Molecular and Structural Biology Division, CSIR-Central Drug Research Institute, Lucknow-226031, India.
Chem Commun (Camb). 2020 Oct 22;56(84):12789-12792. doi: 10.1039/d0cc04415f.
A modular approach for the construction of β- and γ-lactam fused dihydropyrazinones from the readily available Ugi adducts has been described. The sequential construction of rings through base-mediated cycloisomerization followed by acid-mediated cyclization yielded β-lactam fused dihydropyrazinones. However, the Ugi-derived dihydropyrazinones afforded γ-lactam fused dihydropyrazinones under base-mediated cycloisomerization. The regioselectivity in the cycloisomerization reactions is explained on the basis of ring-strain. Substrate scope, limitations and mechanistic investigations through DFT-calculations have been explored.
已描述了一种从易得的 Ugi 加合物构建β-和γ-内酰胺稠合二氢吡嗪酮的模块化方法。通过碱介导的环异构化和酸介导的环化顺序构建环,得到β-内酰胺稠合二氢吡嗪酮。然而,Ugi 衍生的二氢吡嗪酮在碱介导的环异构化下得到γ-内酰胺稠合二氢吡嗪酮。环异构化反应的区域选择性是基于环张力来解释的。通过 DFT 计算探索了底物范围、限制和反应机理的研究。